BMY hires MGH* doctor as CSO: http://investor.bms.com/investors/news-and-events/press-releases/press-release-details/2017/Bristol-Myers-Squibb-Appoints-Dr-Thomas-J-Lynch-Jr-Executive-Vice-President-and-Chief-Scientific-Officer/default.aspx Bristol-Myers Squibb Company today announced that it has appointed Dr. Thomas J. Lynch, Jr., 56, executive vice president and chief scientific officer, effective March 16, 2017. He succeeds Dr. Francis Cuss, 62, who will retire from the company. Dr. Cuss will serve as an advisor to the company for the next three months to ensure a seamless transition.*Massachusetts General Hospital.